BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8103259)

  • 1. Alpha interferon treatment in atopic dermatitis.
    Jullien D; Nicolas JF; Frappaz A; Thivolet J
    Acta Derm Venereol; 1993 Apr; 73(2):130-2. PubMed ID: 8103259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis.
    Paukkonen K; Fräki J; Horsmanheimo M
    Acta Derm Venereol; 1993 Apr; 73(2):141-2. PubMed ID: 8103263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon therapy for atopic dermatitis reduces basophil histamine release, but does not reduce serum IgE or eosinophilic proteins.
    Nielsen BW; Reimert CM; Hammer R; Schiøtz PO; Thestrup-Pedersen K
    Allergy; 1994 Feb; 49(2):120-8. PubMed ID: 7513506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon-alpha-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema.
    Gruschwitz MS; Peters KP; Heese A; Stosiek N; Koch HU; Hornstein OP
    Int Arch Allergy Immunol; 1993; 101(1):20-30. PubMed ID: 8499770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: randomized case-controlled study.
    Noh G; Lee KY
    Cytokine; 2001 Jan; 13(2):124-8. PubMed ID: 11145854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pilot study of the effect of interferon-alpha on atopic eczema].
    Kropp JD; Algermissen B; Buck S; Czarnetzki BM
    Hautarzt; 1994 Apr; 45(4):225-7. PubMed ID: 8014047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha treatment for severe atopic dermatitis.
    Kimata H; Akiyama Y; Kubota M; Furusho K
    Allergy; 1995 Oct; 50(10):837-40. PubMed ID: 8607568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon gamma therapy for atopic dermatitis.
    Hanifin JM; Schneider LC; Leung DY; Ellis CN; Jaffe HS; Izu AE; Bucalo LR; Hirabayashi SE; Tofte SJ; Cantu-Gonzales G
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):189-97. PubMed ID: 8432915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha therapy in atopic dermatitis.
    Torrelo A; Harto A; Sendagorta E; Czarnetzki BM; Ledo A
    Acta Derm Venereol; 1992 Sep; 72(5):370-2. PubMed ID: 1361287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydesensitisation with reducing elevated serum total IgE by IFN-gamma therapy in atopic dermatitis: IFN-gamma and polydesensitisation (PDS).
    Lee JH; Noh G
    Cytokine; 2013 Oct; 64(1):395-403. PubMed ID: 23786862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total serum IgE levels in chronic hepatitis C: influence of interferon alpha therapy.
    González-Quintela A; Alende MR; Lojo S; Pérez LF; Padín E; Tomé S; Vidal C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):176-81. PubMed ID: 11435735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-interferon therapy for severe cases of atopic dermatitis of the adult type.
    Nishioka K; Matsunaga T; Katayama I
    J Dermatol; 1995 Mar; 22(3):181-5. PubMed ID: 7738273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus.
    Thivolet J; Nicolas JF; Kanitakis J; Lyonnet S; Chouvet B
    Br J Dermatol; 1990 Mar; 122(3):405-9. PubMed ID: 2182099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic topical application of salt-processed Phellodendron amurense and Sanguisorba officinalis Linne alleviates atopic dermatitis symptoms by reducing levels of immunoglobulin E and pro-inflammatory cytokines in NC/Nga mice.
    Park S; Kim DS; Kang S; Shin BK
    Mol Med Rep; 2015 Nov; 12(5):7657-64. PubMed ID: 26397864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic dermatitis: the role of recombinant interferon-gamma therapy.
    Chang TT; Stevens SR
    Am J Clin Dermatol; 2002; 3(3):175-83. PubMed ID: 11978138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis.
    Michils A; Farber CM; Van Vooren JP; Yernault JC; Duchateau J
    Br J Dermatol; 1994 Jan; 130(1):134-5. PubMed ID: 8305310
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of interferons in atopic (IgE-mediated) diseases.
    Pung YH; Vetro SW; Bellanti JA
    Ann Allergy; 1993 Sep; 71(3):234-8. PubMed ID: 8372996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor].
    Orozco TT; Solano MO; Sandoval GF; Vera JG; Parra SE
    Rev Alerg Mex; 2004; 51(4):151-4. PubMed ID: 15491080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Intramuscular Injection of Autologous Immunoglobulin on Clinical Severity and Serum IgE Concentration in Patients with Atopic Dermatitis.
    Nahm DH; Kim ME; Cho SM
    Dermatology; 2015; 231(2):145-51. PubMed ID: 26112673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.